Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer (Q24617184)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q28112823)
(Q16231524)
(Q88974435)
(P304) 7146-55
(P407) (Q1860)
(P433) 19
(P478) 53
(P577) Thursday, October 14, 2010
(P921) (Q1418791)
(Q27089007)
(Q32089)
(P1433) (Q900316)
(P1476) "Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer" (language: en)
(P2093) Qingsong Liu
Jae Won Chang
Jinhua Wang
Seong A Kang
Carson C Thoreen
Andrew Markhard
Wooyoung Hur
Jianming Zhang
(P2860) (Q21145847)
(Q24315566)
(Q24599676)
(Q27684091)
(Q27658853)
(Q27851451)
(Q28235431)
(Q28306356)
(Q29614563)
(Q29618117)
(Q37771869)
(Q39694102)
(Q37630203)
(Q39777841)
(Q39803201)
(Q39827828)
(Q37257487)
(Q37398288)
(Q35848445)
(Q34323951)
(Q40659303)
(Q30815339)
(Q36758478)
(Q41227326)
(Q43211411)
(Q46097446)
(Q46544691)
(Q46775832)
(Q44127144)
(Q80629749)
other details
description scientific article

External Links